16 September 2026 editorial review · Trial
LabPatch glucose sensing system accuracy: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the trial evidence page →Primary-agent trial review — 16 September 2026
Assessment: Clarified mixed T1D/T2D insulin-treated population and measurement-study limits; not a cleared dosing sensor.
Registry: NCT05754281; ACTIVE_NOT_RECRUITING; updated 2026-05-29; enrollment 60 (ESTIMATED); results not posted.
Endpoint comparison: Mean absolute relative difference (MARD) (Baseline, every 15 minutes for a total of 6 hours).
Sources for this record: NCT05754281: LabPatch glucose sensing system accuracy (registry).
Limits: Source access and review depth vary. Registry fields establish the registered study, not clinical benefit, product approval or current local access. Cited-source reachability alone was not treated as verification of its claims.